Using Shared Decision Making to Improve Kidney Transplantation Rates

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-12

Study Completion Date

2025-02-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to increase shared decision-making between dialysis providers and patients in order to increase patients' probability of transplantation and to reduce socioeconomic/racial disparities in access to kidney transplantation.

Participants will receive educational material over the course of 4-6 months about different aspects of the kidney transplant and waitlisting process.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision

NCT05879302

End Stage Renal Disease End-Stage Kidney Disease Kidney Transplantation +1 more

RECRUITING NA

Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation

NCT02342119

End-stage Kidney Disease

COMPLETED NA

Increasing Kidney Transplant Among Blacks on the Transplant Waiting List

NCT02319447

Chronic Kidney Disease End-Stage Renal Disease

COMPLETED NA

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

NCT03099434

Kidney Failure Kidney Diseases

ACTIVE_NOT_RECRUITING NA

Social Networks and Renal Education: Promoting Transplantation

NCT03536858

End Stage Renal Disease Living Donor Kidney Transplantation Renal Dialysis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Kidney transplantation is the preferred treatment choice for patients with end stage kidney disease (ESKD), yet only a small proportion of patients with incident ESKD are counseled about their transplant options. Often, a smaller minority of patients reach the transplant waitlist in a timely manner. Increasing the likelihood of transplantation for patients with ESKD can lead to longer survival, better quality of life, and reduced costs of care.

The kidney transplant and waitlist process is a complex and multi-step process that occurs over an extended period of time. This process involves transitions of care between multiple providers and requires patients to be proactive in their medical evaluations.

This study will deliver educational materials to dialysis care teams and provide quarterly, personalized informational letters to patients, with the aim of increasing shared decision-making between patients and providers by giving them the information needed to initiate conversations about kidney transplantation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Renal Disease Kidney Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Enrolled providers and enrolled patients will receive different interventions; outcomes assessed for these two groups will be different.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Providers

Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.

Group Type EXPERIMENTAL

Provider educational materials

Intervention Type BEHAVIORAL

Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.

Patients

Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process.

Group Type EXPERIMENTAL

Patient letters

Intervention Type BEHAVIORAL

Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process. Letters will describe kidney waitlist status, living donor transplantation, Hepatitis C positive kidney transplants, and high Kidney Donor Profile Index (KDPI) transplants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Provider educational materials

Dialysis providers will receive educational material about the kidney transplantation and waitlisting process.

Intervention Type BEHAVIORAL

Patient letters

Dialysis patients will receive letters with information about their status within the kidney transplantation and waitlisting process. Letters will describe kidney waitlist status, living donor transplantation, Hepatitis C positive kidney transplants, and high Kidney Donor Profile Index (KDPI) transplants.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* On a waitlist or undergoing an evaluation at the Columbia University/New York Presbyterian Hospital (CU/NYPH) Transplant Center or at the Cleveland Clinic (CC)
* Receiving hemodialysis at one of the following dialysis clinics:

* Fresenius Kidney Care City Dialysis
* DaVita Kidney Care Haven Dialysis
* DaVita Melrose Dialysis
* DaVita Highbridge Dialysis
* Rogosin Institute East Side Dialysis Unit
* Rogosin Institute West Side Dialysis Unit